A new study shows that ketamine is effective in treating some patients with treatment-resistant depression. The fast-acting drug is effective both in patients with anxiety and in those without it.
Departments, Centers, & Programs:
Clinical Trials Network and Institute
One Bowdoin Square
Boston, MA 02114-2790
- MD, New York University
- Residency, Massachusetts General Hospital
American Board Certifications
- Psychiatry, American Board of Psychiatry and Neurology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Papakostas is involved in overseeing numerous studies focusing on the diagnosis, treatment, and management of Major Depressive Disorder that is resistant or refractory to standard therapy. He is also active in educating clinicians locally, regionally, nationally, and internationally on the management of major depressive disorder, as well as in disseminating cutting-edge research in this field of study through numerous manuscripts published in top-notch scientific journals.